Alex Reidy is always on the lookout for ways to make managing diabetes easier. She recently added inhaled insulin Afrezza into her daily regimen, and dumped her pump. Learn how she uses it in conjunction with long-lasting insulin.
read more →
The FDA recently approved a new rapid-acting mealtime insulin called Lyumjev, which is absorbed into the body more quickly than Humalog and is designed to target post-meal spikes and reduce A1c.
read more →
Fiasp, a rapid-acting insulin for people with type 2 or type 2 diabetes, was recently approved for use in insulin pumps and provides another option for people to help improve their post-meal blood sugars.
read more →
Inhaled insulin Afrezza is a great option for a lot of people living with type 1 and type 2 diabetes because it doesn’t involve shots and has a rapid on-rapid off effect. The makers of Afrezza just announced a direct purchase program to help people get it for as little as $4 a day.
read more →
With several new fast-acting insulins on the market, is it still necessary to pre-bolus before meals? How fast-acting are they really? Endocrinologist and type 1 Dr. Jeremy Pettus compares, contrasts, and gives his vote.
read more →
